SKUNF (Seikagaku) Other Stockholders Equity: $89.0 Mil (As of Mar. 2026)


SKUNF Seikagaku Corp SKUNF
72 GF Score
Price $4.44
GF Value $17.00
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Seikagaku Other Stockholders Equity?

Seikagaku SKUNF +0.91% 72 Other Stockholders Equity is $89.0 Mil as of Mar. 2026. GuruFocus rates SKUNF with a GF Score™ of 72/100 and a GF Value™ of $17.00 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Seikagaku's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $89.0 Mil.

Seikagaku's quarterly Other Stockholders Equity increased from Sep. 2025 ($77.7 Mil) to Dec. 2025 ($78.2 Mil) and increased from Dec. 2025 ($78.2 Mil) to Mar. 2026 ($89.0 Mil).

Seikagaku's annual Other Stockholders Equity increased from Mar. 2024 ($71.2 Mil) to Mar. 2025 ($79.6 Mil) and increased from Mar. 2025 ($79.6 Mil) to Mar. 2026 ($89.0 Mil).

Seikagaku Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Seikagaku's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seikagaku Other Stockholders Equity Chart

Seikagaku Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.59 47.72 71.16 79.59 89.01

Seikagaku Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.59 78.40 77.73 78.21 89.01
SKUNF
72GF Score
Seikagaku Corp SKUNF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seikagaku Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $89.0 Mil mean?
Seikagaku (SKUNF) has a Other Stockholders Equity of $89.0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Seikagaku and its competitors.
Is Seikagaku's Other Stockholders Equity too high?
Seikagaku's current Other Stockholders Equity is $89.0 Mil. Overall, Seikagaku has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seikagaku's Other Stockholders Equity compare to ABT and SYK?
Seikagaku's Other Stockholders Equity of $89.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Seikagaku and its competitors. Seikagaku's current Other Stockholders Equity is $89.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seikagaku stock overvalued right now?
Based on GuruFocus' analysis, Seikagaku (SKUNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.00, compared to a current price of $4.44 — trading 73.9% below its estimated fair value. The current Other Stockholders Equity is $89.0 Mil. Seikagaku's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Seikagaku (SKUNF), the current Other Stockholders Equity is $89.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seikagaku (SKUNF) Overvalued in 2026?

Based on GuruFocus' analysis, Seikagaku stock appears to be undervalued. The current stock price of $4.44 is trading 73.9% below its estimated GF Value™ of $17.00. GuruFocus considers Seikagaku to be Significantly Undervalued.

Key valuation signals for SKUNF:

  • Other Stockholders Equity: $89.0 Mil
  • GF Value™: $17.00 vs. price of $4.44 (73.9% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the SKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seikagaku Business Description

Other Exchanges 4548:Japan
Address Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.
72GF Score

Get the complete analysis for SKUNF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.44
Price
$17.00
GF Value